🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

850 results for “Elan” Clear

  1. BFB759, Placebo

    Blue Earth Diagnostics Ireland Ltd

    Atopic dermatitis

    phase 2 small molecule active

    1 trial

  2. BHV-7000, BHV-7000

    Biohaven Bioscience Ireland Limited

    Refractory Focal Onset Epilepsy

    phase 2 small molecule active

    1 trial

  3. BHV-7000, BHV-7000, Placebo for BHV-7000

    Biohaven Bioscience Ireland Limited

    Refractory Focal Onset Epilepsy

    phase 2 small molecule active

    1 trial

  4. BINIMETINIB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB, IPILIMUMAB, ENCORAFENIB

    Pfizer Australia Pty Ltd

    Metastatic or unresectable locally advanced BRAF V600E/K mutation positive melanoma

    phase 2 small molecule active

    1 trial

  5. BNT111

    Regeneron UK Limited

    Melanoma Stage III

    phase 2 mab completed

    1 trial

  6. BNT111, LIBTAYO 350 mg concentrate for solution for infusion.

    BioNTech SE

    Melanoma (Stage III and IV)

    phase 2 small molecule active

    1 trial

  7. BSF 208075

    Gilead Sciences Ireland UC

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  8. Bevacizumab

    United Therapeutics Europe Ltd

    Metastatic Melanoma

    phase 2 mab completed

    1 trial

  9. Bicarbonate de sodium

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Disease

    phase 2 small molecule completed

    1 trial

  10. Bioengineered Artificial Mesenchimal Sheet (BAMS)

    Lxo Ireland Designated Activity Company

    Venous Ulcer

    phase 2 mab active

    1 trial

  11. Bone marrow mesenchymal stem cells autologous

    Lxo Ireland Designated Activity Company

    Multiple Sclerosis

    phase 2 other completed

    1 trial

  12. Bone marrow mononuclear cells

    Lxo Ireland Designated Activity Company

    Chronic Myocardial Ischemia

    phase 2 other completed

    1 trial

  13. Braftovi 75 mg hard capsules, LIBTAYO 350 mg concentrate for solution for infusion., Mektovi 15 mg film-coated tablets, Fianlimab, Braftovi 50 mg hard capsules

    Disc Medicine

    Melanoma

    phase 2 small molecule active

    1 trial

  14. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Infection

    phase 2 small molecule completed

    1 trial

  15. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Disease

    phase 2 small molecule completed

    1 trial

  16. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus

    phase 2 small molecule terminated

    2 trials

  17. CBD 400 mg

    Jazz Pharmaceuticals Ireland Limited

    Opiate Addiction

    phase 2 small molecule completed

    1 trial

  18. CBD Oral Solution

    Jazz Pharmaceuticals Ireland Limited

    Fragile X Syndrome

    phase 2 small molecule active

    1 trial

  19. CBD Oral Solution (eCBD system Target)

    Jazz Pharmaceuticals Ireland Limited

    Fragile X Syndrome

    phase 2 small molecule active

    1 trial

  20. CMB305

    Lxo Ireland Designated Activity Company

    Sarcoma

    phase 2 mab terminated

    2 trials

  21. CMX001

    Jazz Pharmaceuticals Ireland Limited

    Ebola Virus

    phase 2 small molecule terminated

    1 trial

  22. CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Colorectal Neoplasms

    phase 2 small molecule completed

    1 trial

  23. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Myeloid Neoplasm

    phase 2 small molecule active

    1 trial

  24. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Lymphoid Leukemia

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources